Patent · US Active

Anti-TNFRSF9 antibodies and uses thereof

US11292849B2 · kind B2 · utility

0Cited by

6References

33Claims

0Family size

Assignee

Eucure (Beijing) Biopharma Co., Ltd · CN

Inventors

Yi Yan Yang · Singapore, SG
Jingshu Xie · Beijing, CN
Chunyan Dong · Beijing, CN
Fang Yang · Beijing, CN
Chengyuan Lu · Beijing, CN
Yuelei Shen · Beijing, CN
Jian Ni · Rockville, US
Yanan Guo · Beijing, CN
Yunyun Chen · Beijing, CN

Key dates

Filing date	Mar 12, 2021
Grant date	Apr 5, 2022
Priority date	—
Expiry date	Mar 12, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This disclosure relates to anti-TNFRSF9 (tumor necrosis factor receptor superfamily member 9) antibodies, antigen-binding fragments, and the uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.